Artemisinin: A Panacea Eligible for Unrestrictive Use?

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Drug Discovery

Background:

• Artemisinin is a well-established anti-malarial drug.
• Emerging evidence suggests artemisinin possesses therapeutic potential for metabolic disorders like obesity and diabetes, as well as aging-related diseases.
• The broad therapeutic applications of artemisinin are currently under debate.

Purpose of the Study:

• To discuss the potential for artemisinin to treat a wider spectrum of diseases beyond malaria.
• To analyze the multi-target and non-specific characteristics of artemisinin.
• To evaluate the predisposition of increased malarial resistance to artemisinin due to its broad-acting properties.

Main Methods:

• Literature review and analysis of existing research on artemisinin's pharmacological effects.
• Examination of artemisinin's mechanisms of action across different disease models.
• Risk assessment of artemisinin resistance development in malaria parasites.

Main Results:

• Artemisinin exhibits anti-malarial, anti-tumor, and beneficial effects on metabolic disorders.
• The multi-target and non-specific nature of artemisinin is a key feature.
• Concerns exist regarding the potential for artemisinin to induce resistance in malaria parasites.

Conclusions:

• Artemisinin's broad therapeutic potential extends beyond malaria to metabolic and aging-related diseases.
• The non-specific action of artemisinin raises concerns about the development of drug resistance in malaria.
• Careful consideration of artemisinin's properties is necessary for its expanded therapeutic application, particularly balancing benefits against resistance risks.